Found 5 matching trials
The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease
N/ADiffuse Parenchymal Lung Disease(DPLD) is a chronic progressive fibrosis lu...
Location
First Affiliated Hospital of Guangzhou Medical university
Longitudinal Changes in Serum KL-6 in IPF
N/AIdiopathic pulmonary fibrosis (IPF) is a chronic lung disease with a poor p...
Location
Manchester University hospitals NHS Foundation Trust
Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET
NAThe main purpose of follow-up in asymptomatic breast cancer patients during...
Status
Active Not Recruiting
Location
Azienda Sanitaria dell'Alto Adige - Ospedale di Bressanone
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma
PHASE1Intrahepatic cholangiocarcinoma (ICC) is one of the most common liver malig...
Location
The second affiliated hospital of Zhejiang University
Diagnostic Value of KL-6 in ILD
N/AKL-6 may be a useful biomarker in patients with interstitial lung disease, ...
Location
Hospital de la Santa Creu i Sant Pau